A 17-year-old mixed race male has been followed in our adolescent clinic for severe obesity, dysmorphic features, and behavioral issues. Among other interventions, he has received symptomatic treatment for hypertension, insulin resistance, and attention deficit hyperactivity disorder. Genetic investigation identified a 16p11.2 microdeletion, commonly associated with severe obesity and developmental delay. We present the clinical history, treatment, and implications for this patient.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1515/ijamh-2016-0041 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!